Trial Profile
Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Pharmacodynamics; Therapeutic Use
- 08 Jan 2013 New trial record